🟢 Quantum BioPharma Ltd. is trading 10.3% up today as it rebounds from a multi-session selloff following an FDA clinical hold

Quantum BioPharma Ltd. is trading at $4.70 (up 10.3%) in pre-market, attempting to recover from a sharp multi-session decline triggered by an FDA clinical hold on its lead multiple sclerosis candidate.

• The stock previously saw significant downward pressure, falling 8.2% on June 4 and 7.1% on June 5 following the regulatory update.
• No new company-specific catalysts were identified this morning, suggesting the current move is a technical bounce amid mixed to slightly risk-on broader market conditions.
• Volatility is expected to remain high as the market continues to assess the impact of the clinical hold on the company's primary development pipeline.